Fatty acid signaling: The new function of intracellular lipases

International Journal of Molecular Sciences

Volumn 16, Issue 2, 2015, Pages 3831-3855

  Papackova, Zuzana ^a   Cahova, Monika ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Adipose triacylglycerol lipase; Free fatty acids; Hormone sensitive lipase; Intracellular signaling; Lysosomal lipase

Indexed keywords

ACID LIPASE; ACYLGLYCEROL LIPASE; ADIPOPHILIN; APOLIPOPROTEIN B; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIC AMP DEPENDENT PROTEIN KINASE; FARNESOID X RECEPTOR; FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE; HORMONE SENSITIVE LIPASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERCELLULAR ADHESION MOLECULE 1; LIVER X RECEPTOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOUNSATURATED FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL LIPASE; UNCOUPLING PROTEIN 1; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; FATTY ACID; TRANSCRIPTION FACTOR;

ANTIOXIDANT RESPONSIVE ELEMENT; BROWN ADIPOCYTE; CAPILLARY ENDOTHELIAL CELL; CHOLESTEROL ESTERIFICATION; ENDOPLASMIC RETICULUM; FATTY ACID DESATURATION; FATTY ACID OXIDATION; GENE EXPRESSION; HUMAN; HYPOTHALAMUS; INFLAMMATION; INTRACELLULAR SIGNALING; LIPOGENESIS; LIPOPHAGOCYTOSIS; MACROPHAGE ACTIVATION; METABOLIC REGULATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WHITE ADIPOCYTE; ANIMAL; ANTIBODY SPECIFICITY; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; FATTY ACIDS; HUMANS; LIPASE; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84922567260     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16023831     Document Type: Review

References (134)

1. Aoun, M.; Feillet-Coudray, C.; Fouret, G.; Chabi, B.; Crouzier, D.; Ferreri, C.; Chatgilialoglu, C.; Wrutniak-Cabello, C.; Cristol, J.P.; Carbonneau, M.A. et al.Rat liver mitochondrial membrane characteristics and mitochondrial functions are more profoundly altered by dietary lipid quantity than by dietary lipid quality: Effect of different nutritional lipid patterns. Br. J. Nutr.2012, 107, 647–659.
2. Body, D.R. The lipid composition of adipose tissue. Prog. Lipid Res.1988, 27, 39–60.
3. Field, C.J.; Clandinin, M.T. Modulation of adipose tissue fat composition by diet: A review. Nutr. Res.1984, 4, 743–755.
4. Vessby, B.; Gustafsson, I.B.; Tengblad, S.; Boberg, M.; Andersson, A. Desaturation and elongation of fatty acids and insulin action. Ann. N. Y. Acad. Sci.2002, 967, 183–189.
5. Jump, D.B. The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem.2002, 277, 8755–8758.
6. Ma, D.W.; Seo, J.; Davidson, L.A.; Callaway, E.S.; Fan, Y.Y.; Lupton, J.R.; Chapkin, R.S. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J. 2004, 18, 1040–1042.
7. Jump, D.B.; Tripathy, S.; Depner, C.M. Fatty acid-regulated transcription factors in the liver. Annu. Rev. Nutr.2013, 33, 249–269.
8. Ma, D.W.; Seo, J.; Switzer, K.C.; Fan, Y.Y.; McMurray, D.N.; Lupton, J.R.; Chapkin, R.S. n-3 PUFA and membrane microdomains: A new frontier in bioactive lipid research. J. Nutr. Biochem. 2004, 15, 700-706.
9. Adkins, Y.; Kelley, D.S. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J. Nutr. Biochem.2010, 21, 781-792.
10. Bagga, D.; Wang, L.; Farias-Eisner, R.; Glaspy, J.A.; Reddy, S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA2003, 100, 1751-1756.
11. Novak, T.E.; Babcock, T.A.; Jho, D.H.; Helton, W.S.; Espat, NJ. NF-kB inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-a transcription. Am. J. Physiol. Lung Cell. Mol. Physiol.2003, 284, L84-L89.
12. Malhi, H.; Gores, G.J. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis.2008, 28, 360-369.
13. Legrand-Poels, S.; Esser, N.; L’homme, L.; Scheen, A.; Paquot, N.; Piette, J. Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes. Biochem. Pharmacol.2014, 92, 131-141.
14. Jackson Kim, G.; Jackson, KG.; Maitin, V.; Leake, D.S.; Yaqoob, P.; Williams, Ch.M. Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells. J. Lipid Res. 2006, 47, 393-403.
15. Lin, J.; Yang, R.; Tarr, P.T.; Wu, P.H.; Handschin, C.; Li, S.; Yang, W.; Pei, L.; Uldry, M.; Tontonoz, P. et al.Hyperlipidemic effects of dietary saturated fats mediated through PGC-1b coactivation of SREBP. Cell 2005,120, 261-273.
16. Jump, D.B.; Botolin, D.; Wang, Y.; Xu, J.; Christian, B.; Demeure, O. Fatty acid regulation of hepatic gene transcription. J. Nutr.2005, 135, 2503-2506.
17. Furuhashi, M.; Hotamisligil, G.S. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov.2008, 7, 489-503.
18. Kersten, S.; Desvergne, B.; Wahli, W. Roles of PPARs in health and disease. Nature2000, 405, 421-424.
19. Mangelsdorf, D.J.; Thummel, C.; Beato, M.; Herrlich, P.; Schutz, G.; Umesono, K.; Blumberg, B.; Kastner, P.; Mark, M.; Chambon, P. et al.The nuclear receptor superfamily: The second decade. Cell1995, 83, 835-839.
20. Forman, B.M.; Tontonoz, P.; Chen, J.; Brun, R.P.; Spiegelman, B.M.; Evans, RM. 15-Deoxy-A12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARy. Cell1995, 83, 803-812.
21. Schmitz, G.; Ecker, J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res.2008, 47, 147-55.
22. Nakamura, M.T.; Yudell, BE.; Loor, J.J. Regulation of energy metabolism by long-chain fatty acids. Prog. Lipid Res.2014, 53, 124-144.
23. Rakhshandehroo, M.; Knoch, B.; Muller, M.; Kersten, S. Peroxisome proliferator-activated receptor a target genes. Cell. Mol. Life Sci.2004, 61, 393-416.
24. Kersten, S.; Seydoux, J.; Peters, J.M.; Gonzalez, F.J.; Desvergne, B.; Wahli, W. Peroxisome proliferator-activated receptor a mediates the adaptive response to fasting. J. Clin. Investig.1999, 103, 1489-1498.
25. Luquet, S.; Lopez-Soriano, J.; Holst, D.; Fredenrich, A.; Melki, J.; Rassoulzadegan, M.; Grimaldi, P.A. Peroxisome proliferator-activated receptor 6 controls muscle development and oxidative capability. FASEB J. 2003, 17, 2299-2301.
26. Kannisto, K.; Chibalin, A.; Glinghammar, B.; Zierath, J.R.; Hamsten, A.; Ehrenborg, E. Differential expression of peroxisomal proliferator activated receptors a and 6 in skeletal muscle in response to changes in diet and exercise. Int. J. Mol. Med.2006, 17, 45-52.
27. Pilegaard, H.; Osada, T.; Andersen, L.T.; Helge, J.W.; Saltin, B.; Neufer, P.D. Substrate availability and transcriptional regulation of metabolic genes in human skeletal muscle during recovery from exercise. Metabolism2005, 54, 1048-1055.
28. Motojima, K.; Passilly, P.; Peters, J.M.; Gonzalez, F.J.; Latruffe, N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor a and y activators in a tissue- and inducer-specific manner. J. Biol. Chem.1998, 273, 16710-16714.
29. Tontonoz, P.; Hu, E.; Spiegelman, B.M. Stimulation of adipogenesis in fibroblasts by PPAR y2, a lipid-activated transcription factor. Cell1994, 79, 1147-1156.
30. Dalen, K.T.; Schoonjans, K.; Ulven, S.M.; Weedon-Fekjaer, M.S.; Bentzen, T.G.; Koutnikova, H.; Auwerx, J.; Nebb, H.I. Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-y. Diabetes2004, 53, 1243-1252.
31. Sears, D.D.; Hsiao, A.; Ofrecio, J.M.; Chapman, J.; He, W.; Olefsky, J.M. Selective modulation of promoter recruitment and transcriptional activity of PPARy.Biochem. Biophys. Res. Commun.2007, 364, 515-521.
32. Devine, J.H.; Eubank, D.W.; Clouthier, D.E.; Tontonoz, P.; Spiegelman, B.M.; Hammer, R.E.; Beale, E.G. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor y and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J. Biol. Chem. 1999, 274, 13604-13612.
33. Guan Y. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease. Minerva Urol. Nefrol.2002, 54, 65-79.
34. Grey, S.L.; Nora, E.D.; Vidal-Puig, A.J. Mouse model of PPAR-y deficiency: Dissecting PPAR-y’s role in metabolic homeostasis. Biochem. Soc. Trans.2005, 33, 1053-1058.
35. Matsusue, K.; Haluzik, M.; Lambert, G.; Yim, S.H.; Gavrilova, O.; Ward, J.M.; Brewer, B., Jr; Reitman, ML.; Gonzalez, F.J. Liver-specific disruption of PPARy in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Investig.2003, 111, 737-747.
36. Gavrilova, O.; Haluzik, M.; Matsusue, K.; Cutson, J.J.; Johnson, L.; Dietz, K.R.; Nicol, C.J.; Vinson, C.; Gonzalez, F.J.; Reitman, M.L. Liver peroxisome proliferator-activated receptor y contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem.2003, 278, 34268-34276.
37. Akiyama, T.E.; Sakai, S.; Lambert, G.; Nicol, C.J.; Matsusue, K.; Pimprale, S.; Lee, Y.H.; Ricote, M.; Glass, C.K.; Brewer, H.B., Jr. et al.Conditional disruption of the peroxisome proliferator-activated receptor y gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell. Biol2002, 22, 2607-2619.
38. Rosen, E.D.; Kulkarni, R.N.; Sarraf, P.; Ozcan, U.; Okada, T.; Hsu, C.H.; Eisenman, D.; Magnuson, M.A.; Gonzalez, F.J.; Kahn, C.R. et alTargeted elimination of peroxisome proliferator-activated receptor y in p cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol Cell Biol2003, 23, 7222-7229.
39. Horton, J.D.; Goldstein, J.L.; Brown, M.S. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Investig.2002, 109, 1125-1131.
40. Clarke, S.D.; Gasperikova, D.; Nelson, C.; Lapillonne, A.; Heird, W.C. Fatty acid regulation of gene expression: A genomic explanation for the benefits of the mediterranean diet. Ann. N. Y. Acad. Sci.2002, 967, 283-298.
41. Bennett, M.K.; Toth, J.I.; Osborne, T.F. Selective association of sterol regulatory element-binding protein isoforms with target promoters in vivo. J. Biol Chem. 2004, 279, 37360-37367.
42. Hirano, Y.; Yoshida, M.; Shimizu, M.; Sato, R. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway. J. Biol Chem.2001, 276, 36431-36437.
43. Xu, J.; Nakamura, M.T.; Cho, H.P.; Clarke, S.D. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J. Biol Chem.1999, 274, 23577-23583.
44. Worgall, T.S.; Sturley, S.L.; Seo, T.; Osborne, T.F.; Deckelbaum, R.J. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol Chem.1998, 273, 25537-25540.
45. Xu, J.; Teran-Garcia, M.; Park, J.H.; Nakamura, M.T.; Clarke, S.D. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J. Biol Chem.2001, 276, 9800-9807.
46. Botolin, D.; Wang, Y.; Christian, B.; Jump, D.B. Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways. J. Lipid Res.2006, 47, 181-192.
47. Yoshikawa, T.; Shimano, H.; Yahagi, N; Ide, T.; Amemiya-Kudo, M.; Matsuzaka, T.; Nakakuki, M.; Tomita, S.; Okazaki, H.; Tamura, Y. et al.Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol Chem.2002, 277, 1705-1711.
48. Repa, J.J.; Liang, G; Ou, J.; Bashmakov, Y.; Lobaccaro, J.M.; Shimomura, I.; Shan, B.; Brown, M.S.; Goldstein, J.L.; Mangelsdorf, D.J. Regulation of mouse sterol regulatory element binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRa and LXRp. Genes Dev. 2000, 14, 2819-2830.
49. Ou, J.F.; Tu, H.; Shan, B.; Luk, A.; DeBose-Boyd, R.A.; Bashmakov, Y; Goldstein, J.L.; Brown, M.S. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA2001, 98, 6027-6032.
50. Anderson, E.J.; Thayne, K.; Harris, M.; Carraway, K.; Shaikh, S.R. Aldehyde stress and up-regulation of Nrf2-mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed N-3 polyunsaturated fatty acids. Biochem. J.2012, 441, 359-366.
51. Tang, W.; Jiang, Y.F.; Ponnusamy, M.; Diallo, M. Role of Nrf2 in chronic liver disease. World J. Gastroenterol.2014, 20, 13079-13087.
52. Georgiadi, A.; Kersten, S. Mechanism of gene regulation by fatty acids.Adv. Nutr.2012, 3, 127-134.
53. Fan, M.; Wang, X.; Xu, G.; Yan, Q.; Huang, W. Bile acid signaling and liver regeneration. Biochim. Biophys. Acta2015, 1849, 196-200.
54. Li, Y.; Jadhav, K.; Zhang, Y. Bile acid receptors in non-alcoholic fatty liver disease. Biochem. Pharmacol.2013, 86, 1517-1524.
55. Zhao, A.; Yu, J.; Lew, J.L.; Huang, L.; Wright, S.D.; Cui, J. Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. DNA Cell Biol. 2004, 23, 519-526.
56. Chmurzyhska, A. The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism. J. Appl. Genet.2006, 47, 39-48.
57. Hanhoff, T.; Lücke, C.; Spener, F. Insights into binding of fatty acids by fatty acid binding proteins. Mol. Cell. Biochem.2002, 239, 45-54.
58. Xu, L.Z.; Sánchez, R.; Sali, A.; Heintz, N. Ligand specificity of brain lipid-binding protein. J. Biol Chem.1996, 271, 24711-24719.
59. Wolfrum, C.; Borrmann, CM.; Borchers, T.; Spener, F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors a—And y-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus. Proc. Natl. Acad. Sci. USA 2001, 98, 2323-2328.
60. Tan, N.S.; Shaw, N.S.; Vinckenbosch, N.; Liu, P.; Yasmin, R.; Desvergne, B.; Wahli, W.; Noy, N. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol. Cell. Biol.2002, 22, 5114-5127.
61. Khan, S.H.; Sorof, S. Liver fatty acid-binding protein: Specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc. Natl. Acad. Sci. USA1994, 91, 848-852.
62. Boneva, N.B.; Kikuchi, M.; Minabe, Y.; Yamashima, T. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: Implication of fatty acid-binding proteins (FABP) and G protein-coupled receptor 40 (GPR40) in adult neurogenesis. J. Pharmacol. Sci. 2011, 116, 163-172.
63. Raclot, T.; Groscolas, R. Differential mobilization of white adipose tissue fatty acids according to chain length, unsaturation, and positional isomerism. J. Lipid Res.1993, 34, 1515-1526.
64. Raclot, T.; Oudart, H. Selectivity of fatty acids on lipid metabolism and gene expression. Proc. Nutr. Soc.1999, 58, 633-646.
65. Pinent, M.; Hackl, H.; Burkard, T.R.; Prokesch, A.; Papak, C.; Scheideler, M.; Hämmerle, G.; Zechner, R.; Trajanoski, Z.; Strauss, J.G. Differential transcriptional modulation of biological processes in adipocyte triglyceride lipase and hormone-sensitive lipase-deficient mice. Genomics2008, 92, 26-32.
66. Haemmerle, G.; Zimmermann, R.; Strauss, J.G.; Kratky, D.; Riederer, M.; Knipping, G.; Zechner, R. Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle. J. Biol. Chem.2002, 277, 12946–12952.
67. Osuga, J.; Ishibashi, S.; Oka, T.; Yagyu, H.; Tozawa, R.; Fujimoto, A.; Shionoiri, F.; Yahagi, N.; Kraemer, F.B.; Tsutsumi, O. et al.Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc. Natl. Acad. Sci. USA2000, 97, 787–792.
68. Harada, K.; Shen, W.J.; Patel, S.; Natu, V.; Wang, J.; Osuga, J.; Ishibashi, S.; Kraemer, F.B. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. Am. J. Physiol. Endocrinol. Metab.2003, 285, E1182–E1195.
69. Wang, S.P.; Laurin, N.; Himms-Hagen, J.; Rudnicki, M.A.; Levy, E.; Robert, M.F.; Pan, L.; Oligny, L.; Mitchell, G.A. The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes. Res.2001, 9, 119–128.
70. Roduit, R.; Masiello, P.; Wang, S.P.; Li, H.; Mitchell, G.A.; Prentki, M. A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: A study in hormone-sensitive lipase-deficient mice. Diabetes2001, 50, 1970–1975.
71. Du, H.; Heur, M.; Duanmu, M.; Grabowski, G.A.; Hui, D.Y.; Witte, D.P.; Mishra, J. Lysosomal acid lipase-deficient mice: Depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span. J. Lipid Res.2001, 42, 489–500.
72. Finn, P.F.; Dice, J.F. Proteolytic and lipolytic responses to starvation. Nutrition2006, 22, 830–844.
73. Singh, R.; Kaushik, S.; Wang, Y.; Xiang, Y.; Novak, I.; Komatsu, M.; Tanaka, K.; Cuervo, A.M.; Czaja, M.J. Autophagy regulates lipid metabolism. Nature2009, 458, 1131–1135.
74. Dolinsky, V.W.; Gilham, D.; Alam, M.; Vance, D.E.; Lehner, R. Triacylglycerol hydrolase: Role in intracellular lipid metabolism. Cell. Mol. Life Sci.2004, 61, 1633–1651.
75. Wei, E.; Ben Ali, Y.; Lyon, J.; Wang, H.; Nelson, R.; Dolinsky, V.W.; Dyck, J.R.; Mitchell, G.; Korbutt, G.S.; Lehner, R. Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metab. 2010, 11, 183–193.
76. Lian, J.; Wei, E.; Wang, S.P.; Quiroga, A.D.; Li, L.; di Pardo, A.; van der Veen, J.; Sipione, S.; Mitchell, G.A.; Lehner, R. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice. Hepatology2012, 56, 2154–2162.
77. Wang, H.; Wei, E.; Quiroga, A.D.; Sun, X.; Touret, N.; Lehner, R. Altered lipid droplet dynamics in hepatocytes lacking triacylglycerol hydrolase expression. Mol. Biol. Cell2010, 21, 1991–2000.
78. Yeaman, S.J. Hormone-sensitive lipase—New roles for an old enzyme. Biochem. J.2004, 379, 11–22.
79. Tansey, J.T.; Sztalryd, C.; Hlavin, E.M.; Kimmel, A.R.; Londos, C. The central role of perilipin a in lipid metabolism and adipocyte lipolysis. IUBMB Life2004, 56, 379–385.
80. Londos, C.; Brasaemle, D.L.; Schultz, C.J.; Segrest, J.P.; Kimmel, A.R. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin. Cell Dev. Biol.1999, 10, 51–58.
81. Su, C.L.; Sztalryd, C.; Contreras, J.A.; Holm, C.; Kimmel, A.R.; Londos, C. Mutational analysis of the hormone-sensitive lipase translocation reaction in adipocytes. J. Biol. Chem.2003, 278, 43615–43619.
82. Sztalryd, C.; Xu, G.; Dorward, H.; Tansey, J.T.; Contreras, J.A.; Kimmel, A.R.; Londos, C. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J. Cell Biol.2003, 161, 1093–1103.
83. Sengenes, C.; Bouloumie, A.; Hauner, H.; Berlan, M.; Busse, R.; Lafontan, M.; Galitzky, J. Involvement of a cGMP-dependent pathway in the natriuretic peptidemediated hormone-sensitive lipase phosphorylation in human adipocytes. J. Biol. Chem.2003, 278, 48617–48626.
84. Lampidonis, A.D.; Rogdakis, E.; Voutsinas, G.E.; Stravopodis, D.J. The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis. Gene2011, 477, 1–11.
85. Daval, M., Diot-Dupuy, F.; Bazin, R.; Hainault, I.; Viollet, B.; Vaulont, S.; Hajduch, E.; Ferré, P.; Foufelle, F. Antilipolytic action of AMP-activated protein kinase in rodent adipocytes. J. Biol. Chem.2005, 280, 25250–25257.
86. Castro-Chavez, F.; Yechoor, V.K.; Saha, P.K.; Martinez-Botas, J.; Wooten, E.C.; Sharma, S.; O’Connell, P.; Taegtmeyer, H.; Chan, L. Coordinated upregulation of oxidative pathways and downregulation of lipid biosynthesis underlie obesity resistance in perilipin knockout mice: A microarray gene expression profile. Diabetes2003, 52, 2666–2674.
87. Schweiger, M.; Schreiber, R.; Haemmerle, G.; Lass, A.; Fledelius, C.; Jacobsen, P.; Tornqvist, H.; Zechner, R.; Zimmermann, R. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J. Biol. Chem.2006, 281, 40236–40241.
88. Zimmermann, R.; Strauss, J.G.; Haemmerle, G.; Schoiswohl, G.; Birner-Gruenberger, R.; Riederer, M.; Lass, A.; Neuberger, G.; Eisenhaber, F.; Hermetter, A. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science2004, 306, 1383–1386.
89. Zechner, R.; Kienesberger, P.C.; Haemmerle, G.; Zimmermann, R.; Lass, A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J. Lipid Res.2009, 50, 3–21.
90. Subramanian, V.; Rothenberg, A.; Gomez, C.; Cohen, A.W.; Garcia, A.; Bhattacharyya, S.; Shapiro, L.; Dolios, G.; Wang, R.; Lisanti, M.P. Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J. Biol. Chem.2004, 279, 42062–42071.
91. Brasaemle, D.L.; Barber, T.; Wolins, N.E.; Serrero, G.; Blanchette-Mackie, E.J.; Londos, C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid Res.1997, 38, 2249–2263.
92. Listenberger, L.L.; Ostermeyer-Fay, A.G.; Goldberg, E.B.; Brown, W.J.; Brown, D.A. Adipocyte differentiation-related protein reduces the lipid droplet association of adipose triglyceride lipase and slows triacylglycerol turnover. J. Lipid Res.2007, 48, 2751–2761.
93. Yang, X.; Lu, X.; Lombes, M.; Rha, G.B.; Chi, Y.I.; Guerin, T.M.; Smart, E.J.; Liu, J. The G0/G1 switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab. 2010, 11, 194–205.
94. Lu, X.; Yang, X.; Liu, J. Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2. Cell Cycle2010, 9, 2719–2725.
95. Storey, S.M.; McIntosh, A.L.; Senthivinayagam, S.; Moon, K.C.; Atshaves, B.P. The phospholipid monolayer associated with perilipin-enriched lipid droplets is a highly organized rigid membrane structure. Am. J. Physiol. Endocrinol. Metab.2011, 301, E991–E1003.
96. Mehrpour, M.; Esclatine, A.; Beau, I.; Codogno, P. Autophagy in health and disease. 1. Regulation and significance of autophagy: An overview. Am. J. Physiol. Cell Physiol. 2010, 298, C776–C785.
97. Mizushima, N.; Levine, B. Autophagy in mammalian development and differentiation. Nat. Cell Biol.2010, 12, 823–830.
98. Ohsaki, Y.; Cheng, J.; Suzuki, M.; Shinohara, Y.; Fujita, A.; Fujimoto, T. Biogenesis of cytoplasmic lipid droplets: From the lipid ester globule in the membrane to the visible structure. BBA2009, 1791, 399–407.
99. Papáčková, Z.; Cahová, M. Important role of autophagy in regulation of metabolic processes in health, disease and aging. Physiol. Res.2014, 63, 409–420.
100. Cohen, DE. New players on the metabolic stage: How do you like Them Acots? Adipocyte 2013, 2, 3–6.
101. Kirkby, B.; Roman, N.; Kobe, B.; Kellie, S.; Forwood, J.K. Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog. Lipid Res.2010, 49, 366–377.
102. Hunt, M.C.; Alexson, S.E. The role Acyl-CoA thioesterases play in mediating intracellular lipid metabolism. Prog. Lipid Res.2002, 41, 99–130.
103. Zhang, Y.; Li, Y.; Niepel, M.W.; Kawano, Y.; Han, S.; Liu, S.; Marsili, A.; Larsen, P.R.; Lee, C.H.; Cohen, D.E. Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance. Proc. Natl. Acad. Sci. USA2012, 109, 5417–5422.
104. Kang, H.W.; Niepel, M.W.; Han, S.; Kawano, Y.; Cohen, D.E. Thioesterase superfamily member 2/acyl-CoA thioesterase 13 (Them2/Acot13) regulates hepatic lipid and glucose metabolism. FASEB J. 2012, 26, 2209–2221.
105. Maira, S.M.; Galetic, I.; Brazil, D.P.; Kaech, S.; Ingley, E.; Thelen, M. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science2001, 294, 374–380.
106. Parcellier, A.; Tintignac, L.A.; Zhuravleva, E.; Cron, P.; Schenk, S.; Bozulic, L. Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that sensitizes cells to apoptosis. Cell. Signal.2009, 21, 639–650.
107. Zhao, H.; Martin, B.M.; Bisoffi, M.; Dunaway-Mariano, D. The Akt C-terminal modulator protein is an acyl-CoA thioesterase of the Hotdog-Fold family. Biochemistry2009, 48, 5507–5509.
108. Zhuravleva, E.; Gut, H.; Hynx, D.; Marcellin, D.; Bleck, C.K.; Genoud, C. Acyl coenzyme a thioesterase them5/ acot15 is involved in cardiolipin remodeling and fatty liver development. Mol. Cell. Biol.2012, 32, 2685–2697.
109. Clarke, S.D. The multi-dimensional regulation of gene expression by fatty acids: Polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol.2004, 15, 13–18.
110. Chakravarthy, M.V.; Pan, Z.; Zhu, Y.; Tordjman, K.; Schneider, J.G.; Coleman, T.; Turk, J.; Semenkovich, C.F. New hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis. Cell. Metab.2005, 1, 309–322.
111. Ong, K.T.; Mashek, M.T.; Bu, S.Y.; Greenberg, A.S.; Mashek, D.G. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology2011, 53, 116-126.
112. Jha, P.; Claudel, T.; Baghdasaryan, A.; Mueller, M.; Halilbasic, E.; Das, S.K.; Lass, A.; Zimmermann, R.; Zechner, R.; Hoefler, G. et al.Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. Hepatology2014, 59, 858-869.
113. Amri, E.Z.; Ailhaud, G; Grimaldi, P. Regulation of adipose cell differentiation. II. Kinetics of induction of the aP2 gene by fatty acids and modulation by dexamethasone. J. Lipid Res.1991, 32, 1457-14563.
114. Duplus, E.; Glorian, M.; Forest, C. Transcription fatty acid regulation of gene. J. Biol. Chem.2000, 275, 30749-30752.
115. Amri, E.Z.; Bertrand, B.; Ailhaud, G; Grimaldi, P. Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J. Lipid Res.1991, 32, 1449-1456.
116. Forest, C.; Franckhauser, S.; Glorian, M.; Antras-Ferry, J.; Robin, D.; Robin, P. Regulation of gene transcription by fatty acids, fibrates and prostaglandins: The phosphoenolpyruvate carboxykinase gene as a model. Prostaglandins Leukot. Essent. Fatty Acids 1997, 57, 47-56.
117. Flachs, P.; Rühl, R.; Hensler, M.; Janovska, P.; Zouhar, P.; Kus, V.; Macek Jilkova, Z.; Papp, E.; Kuda, O.; Svobodova, M. et al.Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and N-3 fatty acids. Diabetologia 2011, 54, 2626-2638.
118. Sessler, A.M.; Kaur, N.; Palta, J.P.; Ntambi, J.M. Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes. J. Biol. Chem.1996, 271, 29854-29858.
119. Ahmadian, M.; Abbott, M.J.; Tang, T.; Hudak, C.S.; Kim, Y.; Bruss, M.; Hellerstein, M.K.; Lee, H.Y.; Samuel, V.T.; Shulman, G.I. et al.Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab. 2011, 13, 739-748.
120. Mottillo, E.P.; Bloch, A.E.; Leff, T.; Granneman, J.G. Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) a and 6 in brown adipocytes to match fatty acid oxidation with supply. J. Biol. Chem.2012, 287, 25038-25048.
121. Mottillo, E.P.; Granneman, J.G. Intracellular fatty acids suppress P-adrenergic induction of PKA-targeted gene expression in white adipocytes. Am. J. Physiol. Endocrinol. Metab.2011, 301, E122-E131.
122. Mottillo, E.P.; Shen, X.J.; Granneman, J.G. Role of hormone-sensitive lipase in P-adrenergic remodeling of white adipose tissue. Am. J. Physiol. Endocrinol. Metab.2007, 293, E1188-E1197.
123. Haemmerle, G; Moustafa, T.; Woelkart, G; Büttner, S.; Schmidt, A.; van de Weijer, T.; Hesselink, M.; Jaeger, D.; Kienesberger, P.C.; Zierler, K. et al.ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-a and PGC-1. Nat. Med.2011, 17, 1076-1085.
124. Kienesberger, P.C.; Pulinilkunnil, T.; Nagendran, J.; Dyck, J.R. Myocardial triacylglycerol metabolism. J. Mol. Cell. Cardiol.2013, 55, 101-110.
125. Ueno, M.; Suzuki, J.; Zenimaru, Y.; Takahashi, S.; Koizumi, T.; Noriki, S.; Yamaguchi, O.; Otsu, K.; Shen, W.J.; Kraemer, F.B. et al.Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice. Am. J. Physiol. Endocrinol. Metab.2008, 294, E1109–E1118.
126. Suzuki, J.; Shen, W.J.; Nelson, B.D.; Patel, S.; Veerkamp, J.H.; Selwood, S.P.; Murphy, G.M.; Reaven, E.; Kraemer, F.B. Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression. Am. J. Physiol. Endocrinol. Metab.2001, 281, E857–E866.
127. Chandak, P.G.; Radovic, B.; Aflaki, E.; Kolb, D.; Buchebner, M.; Fröhlich, E.; Magnes, C.; Sinner, F.; Haemmerle, G.; Zechner, R. et al.Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J. Biol. Chem.2010, 285, 20192–20201.
128. Lammers, B.; Chandak, P.G.; Aflaki, E.; van Puijvelde, G.H.; Radovic, B.; Hildebrand, R.B.; Meurs, I.; Out, R.; Kuiper, J.; van Berkel, T.J. et al.Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol.2011, 31, 67–73.
129. Aflaki, E.; Radovic, B.; Chandak, P.G.; Kolb, D.; Eisenberg, T.; Ring, J.; Fertschai, I.; Uellen, A.; Wolinski, H.; Kohlwein, S.D. et al.Triacylglycerol accumulation activates the mitochondrial apoptosis pathway in macrophages. J. Biol. Chem.2011, 286, 7418–7428.
130. Varela, L.M.; Ortega-Gomez, A.; Lopez, S.; Abia, R.; Muriana, J.G.; Bermudez, B. The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/macrophage cells. J. Nutr. Biochem.2013, 24, 2031–2039.
131. Xu, H.E.; Lambert, M.H.; Montana, V.G.; Parks, D.J.; Blanchard, S.G.; Brown, P.J. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell1999, 3, 397–403.
132. Lin, Y.; Chiba, S.; Suzuki, A.; Yamaguchi, S.; Nakanishi, T.; Matsumoto, H.; Ikeda, Y.; Ishibashi-Ueda, H.; Hirano, K.; Kato, S. Vascular smooth muscle cells isolated from adipose triglyceride lipase-deficient mice exhibit distinct phenotype and phenotypic plasticity. Biochem. Biophys. Res. Commun.2013, 434, 534–540.
133. Inoue, T.; Kobayashi, K.; Inoguchi, T.; Sonoda, N.; Fujii, M.; Maeda, Y.; Fujimura, Y.; Miura, D.; Hirano, K.; Takayanagi, R. Reduced expression of adipose triglyceride lipase enhances tumor necrosis factor α-induced intercellular adhesion molecule-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-κB. J. Biol. Chem.2011, 286, 32045–32053.
134. Kaushik, S.; Rodriguez-Navarro, J.A.; Arias, E, Kiffin, R.; Sahu, S.; Schwartz, G.J.; Cuervo, A.M.; Singh, R. Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab. 2011, 14, 173–183.